TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32578332

Group type: EXPERIMENTAL
Intervention: TUEB (hexaminolevulinate-guided transurethral en bloc submucosal hydrodissection)
Number of subjects: 115

Group type: COMPARATOR
Intervention: TURBT (conventional hexaminolevulinate-guided transurethral resection of bladder tumour)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: TUEB
Number of subjects: 115

Group type: COMPARATOR
Intervention: TURBT
Number of subjects: 115
Study: 35183773

Group type: EXPERIMENTAL
Intervention: Atezolizumab with antibiotic use
Number of subjects: 4458

Group type: COMPARATOR
Intervention: Atezolizumab without antibiotic use
Number of subjects: 4458

Group type: EXPERIMENTAL
Intervention: Atezolizumab with PPI use
Number of subjects: 4458

Group type: COMPARATOR
Intervention: Atezolizumab without PPI use
Number of subjects: 4458
Study: 33404156

Group type: EXPERIMENTAL
Intervention: Integrated theoretical model-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32598217

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia sac disconnection (Group A)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Laparoscopic hernia sac disconnection with peritoneal closure (Group B)
Number of subjects: 34
Study: 35666229

Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI plus panitumumab
Number of subjects: 435

Group type: COMPARATOR
Intervention: Modified FOLFOX plus panitumumab
Number of subjects: 435
Study: 32321767

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with cisplatin and gemcitabine
Number of subjects: 107

Group type: COMPARATOR
Intervention: Chemoradiation
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 107
Study: 35297493

Group type: EXPERIMENTAL
Intervention: IL-6 inhibitors (e.g., Tocilizumab)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed seroconversion subgroup
Number of subjects: 0
Study: 34154931

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Clinical examination
Number of subjects: 500

Group type: COMPARATOR
Intervention: Incorrect rotation of sites
Number of subjects: 500

Group type: COMPARATOR
Intervention: Insulin syringe reusage for more than five times
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Skin biopsy
Number of subjects: 500
Study: 32109313

Group type: EXPERIMENTAL
Intervention: Ketamine in conjunction with morphine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard morphine equivalent therapy alone
Number of subjects: 50
Study: 35794395

Group type: EXPERIMENTAL
Intervention: Self-help parenting program with biweekly telephonic support
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Self-help parenting program without biweekly telephonic support
Number of subjects: 110

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 110
Study: 33587120

Group type: EXPERIMENTAL
Intervention: Normal TSH (per 1 SD increase)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal FT4 (per 1 SD increase)
Number of subjects: 0
Study: 33399632

Group type: EXPERIMENTAL
Intervention: Single oral dose of 100,000 IU of vitamin D (SG)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Daily oral doses of 400 IU of vitamin D (CG)
Number of subjects: 84
Study: 35365179

Group type: EXPERIMENTAL
Intervention: 60 mg alemtuzumab
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 30 mg alemtuzumab
Number of subjects: 23
Study: 33880019

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 25 ?g twice-daily (BID)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study: 33498955

Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE) over a 12-week monitored intervention followed by a 12-week self-directed intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10-hour time-restricted eating (TRE)
Number of subjects: 0
Study: 35300507

Group type: EXPERIMENTAL
Intervention: Micro-lecture education
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation education
Number of subjects: 100
Study: 32681596

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg·kg‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35700915

Group type: EXPERIMENTAL
Intervention: rTMS-real
Number of subjects: 27

Group type: COMPARATOR
Intervention: rTMS-sham
Number of subjects: 27
Study: 36172943

Group type: EXPERIMENTAL
Intervention: Transcarotid artery revascularization (TCAR)
Number of subjects: 118566

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 118566

Group type: COMPARATOR
Intervention: Transfemoral carotid artery stenting (TF-CAS)
Number of subjects: 118566
Study: 34035087

Group type: EXPERIMENTAL
Intervention: Robot-assisted training plus usual care
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Enhanced upper limb therapy (EULT) programme plus usual care
Number of subjects: 770

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 770
Study: 33132076

Group type: EXPERIMENTAL
Intervention: Education program for hemodialysis patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: No education program (control group)
Number of subjects: 50
Study: 34264757

Group type: EXPERIMENTAL
Intervention: Play and Learn for Surgeons (PLS) game
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study: 32402223

Group type: EXPERIMENTAL
Intervention: Repaired cleft palate with VPI
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Repaired cleft palate with complete velopharyngeal closure
Number of subjects: 15

Group type: COMPARATOR
Intervention: Noncleft anatomy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 15
Study: 36375378

Group type: EXPERIMENTAL
Intervention: High-load resistance training
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Low-load resistance training
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 34134724

Group type: EXPERIMENTAL
Intervention: Practitioner-led referral
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Researcher-led recruitment
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Self-referral
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Overall recruitment
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Research nurse referrals
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Specialist midwives referrals
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Cost of recruitment
Number of subjects: 500
Study: 32933489

Group type: EXPERIMENTAL
Intervention: Systematic fast-track transition to specialised palliative care (SPC) enriched with a psychological intervention at home
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 321
Study: 35185122

Group type: COMPARATOR
Intervention: Nitinol Stent (NS)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Vein Bypass (VBP)
Number of subjects: 209
Study: 34014692

Group type: COMPARATOR
Intervention: EVERYbody Project (dissonance-based body image intervention)
Number of subjects: 239
Study: 33779506

Group type: EXPERIMENTAL
Intervention: Various docking software (Sybyl Surflex-Dock, OpenEye FRED, Hermes GOLD) with twelve different scoring functions.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-docking relaxation in Surflex.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical tools for screening and scoring functions.
Number of subjects: 0
Study: 35545258

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (moderate intensity physical activity twice weekly at a centre and up to four times weekly at home, plus personalised nutritional counselling)
Number of subjects: 1519

Group type: COMPARATOR
Intervention: Education on healthy ageing (control)
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1519
Study: 35657084

Group type: EXPERIMENTAL
Intervention: Vacutainer with cartoon characters
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (standard bloodletting routine)
Number of subjects: 102
Study: 34689841

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Lifetime cannabis and cocaine use disorders
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 97
Study: 32892609

Group type: EXPERIMENTAL
Intervention: Preoperative venous computed tomographic angiography (CTA) combined with 3-dimensional computed tomography (3D CT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Asterion for identification of the TSSJ (Control group)
Number of subjects: 63
Study: 37286883

Group type: EXPERIMENTAL
Intervention: New sexual or physical victimization assessed 6 months after SAMFE via telephone interview.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Predictors of revictimization during follow-up.
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Adjusted models for revictimization.
Number of subjects: 233
Study: 33599561

Group type: EXPERIMENTAL
Intervention: National Swedish Kidney Cancer Register (NSKCR) reporting
Number of subjects: 431
Study: 32350771

Group type: EXPERIMENTAL
Intervention: ED‐PrEP
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Daily PrEP
Number of subjects: 54
Study: 33902125

Group type: EXPERIMENTAL
Intervention: Criteria catalog 1
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Criteria catalog 2
Number of subjects: 349
Study: 32598950

Group type: EXPERIMENTAL
Intervention: Retinal specialists
Number of subjects: 651

Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Retinal specialists (for intraretinal fluid)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA) (for intraretinal fluid)
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: Retinal specialists (for subretinal fluid)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Notal OCT Analyzer (NOA) (for subretinal fluid)
Number of subjects: 651
Study: 34425875

Group type: EXPERIMENTAL
Intervention: Enhanced assisted feedback
Number of subjects: 1797

Group type: EXPERIMENTAL
Intervention: Basic assisted feedback
Number of subjects: 1797

Group type: COMPARATOR
Intervention: Simple feedback
Number of subjects: 1797

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1797
Study: 35550423

Group type: EXPERIMENTAL
Intervention: Rapid Cycle Deliberate Practice (RCDP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Traditional Debriefing
Number of subjects: 33
Study: 34167637

Group type: EXPERIMENTAL
Intervention: Transcutaneous posterior tibial nerve stimulation
Number of subjects: 408

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 408
Study: 35598359

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg bid)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control (enzalutamide or abiraterone)
Number of subjects: 386
Study: 33630641

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 138
Study: 33783254

Group type: EXPERIMENTAL
Intervention: Brain-plasticity computerized cognitive training
Number of subjects: 113

Group type: COMPARATOR
Intervention: Active control group (computer games)
Number of subjects: 113
Study: 33559050

Group type: EXPERIMENTAL
Intervention: Methadone Maintenance Treatment (MMT)
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Control group (5020 patients)
Number of subjects: 1255
Study: 36273449

Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic therapy
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: 14 days of antibiotic therapy
Number of subjects: 604

Group type: COMPARATOR
Intervention: Nonincluded patients (control group)
Number of subjects: 604
Study: 34261072

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (HFNO) delivered by a portable device
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oxygen supplementation by a Venturi mask (Control)
Number of subjects: 20
Study: 36243351

Group type: EXPERIMENTAL
Intervention: S. sonnei-rEPA vaccine (adults)
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Control vaccines (adults)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: S. sonnei-rEPA conjugate (children)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: S. flexneri 2a-rEPA conjugate (children)
Number of subjects: 1857
Study: 32951998

Group type: EXPERIMENTAL
Intervention: Combined cardiothoracic surgery and liver transplantation (cCSLT)
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Isolated liver transplantation (iLT) - random
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Isolated liver transplantation (iLT) - matched
Number of subjects: 1116
Study: 32649352

Group type: EXPERIMENTAL
Intervention: Rivaroxaban and aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: P2Y12 inhibition and aspirin
Number of subjects: 0
Study: 35568940

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 3861
Study: 34530881

Group type: EXPERIMENTAL
Intervention: Epidural morphine administered every 18-24 hours, doses escalated daily (5-10 mg), for a minimum of 2 doses and a maximum of 5 doses (96 hours).
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham catheter (control group) fixed like the intervention group but not entering the epidural space.
Number of subjects: 50
Study: 32702001

Group type: EXPERIMENTAL
Intervention: Antibiotic prescribed
Number of subjects: 35244

Group type: COMPARATOR
Intervention: No antibiotic prescribed
Number of subjects: 35244

Group type: EXPERIMENTAL
Intervention: Consultations for UTI
Number of subjects: 35244

Group type: EXPERIMENTAL
Intervention: Consultations for skin infection
Number of subjects: 35244

Group type: EXPERIMENTAL
Intervention: Consultations for RTI
Number of subjects: 35244

Group type: EXPERIMENTAL
Intervention: Severely frail patients aged 55-64 years
Number of subjects: 35244
Study: 35022859

Group type: EXPERIMENTAL
Intervention: Pelvic vein embolisation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 80
Study: 32342266

Group type: EXPERIMENTAL
Intervention: Topical application of vitamin E on staple lines and anastomoses (G1)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (G2) without vitamin E application
Number of subjects: 140
Study: 34475360

Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg twice daily for 7 days
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Amoxicillin and Placebo (both groups)
Number of subjects: 97
Study: 33186893

Group type: EXPERIMENTAL
Intervention: Stochastic simulation (STOCH)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 11
Study: 36317897

Group type: EXPERIMENTAL
Intervention: Short-term nutritional support for 1 month
Number of subjects: 0
Study: 33929333

Group type: EXPERIMENTAL
Intervention: Adherence-focused guidance enhancement internet-based self-help intervention with social presence
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Adherence-focused guidance enhancement internet-based self-help intervention with impersonal service team
Number of subjects: 775

Group type: COMPARATOR
Intervention: Internet as usual (control group)
Number of subjects: 775
Study: 32130181

Group type: EXPERIMENTAL
Intervention: BCSMS app
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112
Study: 616840873

Group type: EXPERIMENTAL
Intervention: Low fat diet (60% carbohydrate, 20% fat, 20% protein)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (40% carbohydrate, 40% fat, 20% protein)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Very-low carbohydrate diet (10% carbohydrate, 60% fat, 30% protein)
Number of subjects: 21

Group type: COMPARATOR
Intervention: All diets
Number of subjects: 21
Study: 33991416

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 7119

Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 7119
Study: 32147485

Group type: COMPARATOR
Intervention: ACLR alone
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: ACLR with lateral extra-articular tenodesis (LET)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: ACLR with LET
Number of subjects: 618
Study: 36357602

Group type: EXPERIMENTAL
Intervention: Thulium:YAG laser enucleation of the prostate (ThuLEP)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Continuous-wave thulium fiber laser enucleation of the prostate (CW-ThuFLEP)
Number of subjects: 110
Study: 32639254

Group type: EXPERIMENTAL
Intervention: Bilateral, high frequency, dorsomedial prefrontal cortex (DMPFC) rTMS at 10 Hz, 120% of resting motor threshold, for 20 sessions.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham rTMS (control group).
Number of subjects: 29
Study: 34170241

Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (PAP) spontaneous mode
Number of subjects: 32

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 32
Study: 33685834

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 147

Group type: COMPARATOR
Intervention: Taxane
Number of subjects: 147
Study: 35229407

Group type: EXPERIMENTAL
Intervention: MM-FAT (multimodal approach to food art therapy)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 39
Study: 33852887

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 750

Group type: COMPARATOR
Intervention: Metabolic syndrome
Number of subjects: 750
Study: 32319528

Group type: EXPERIMENTAL
Intervention: ZYN 3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZYN 6 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZYN 8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: General 8 mg snus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Longhorn Natural 18 mg moist snuff
Number of subjects: 0

Group type: COMPARATOR
Intervention: General 2 × 8 mg snus pouches
Number of subjects: 0
Study: 35567304

Group type: EXPERIMENTAL
Intervention: Acute alcohol condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 0
Study: 34323443

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.4 microgram/kg bolus followed by 0.4 microgram/kg/h infusion)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline placebo (Control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 45
Study: 35425838

Group type: EXPERIMENTAL
Intervention: Hippocampal sparing whole-brain radiotherapy (HS-WBRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 40
Study: 34130725

Group type: EXPERIMENTAL
Intervention: Customized protocol for structuring communication between clinicians in the OR and the ICU
Number of subjects: 12
Study: 32709710

Group type: EXPERIMENTAL
Intervention: Regional anesthesia (brachial plexus block; 0.5% L-bupivacaine and 1.5% lidocaine with epinephrine)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Local anesthesia (0.5% L-bupivacaine and 1% lidocaine)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 126
Study: 34813391

Group type: EXPERIMENTAL
Intervention: NIV alternating with high-flow nasal oxygen
Number of subjects: 623

Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 623
Study: 33434282

Group type: EXPERIMENTAL
Intervention: Hybrid Hyrax (HH) expander
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Hyrax (CH) expander
Number of subjects: 40
Study: 33027168

Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty (HA)
Number of subjects: 1441

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty (THA)
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Surgeons with no fellowship training
Number of subjects: 1441
Study: 35471196

Group type: EXPERIMENTAL
Intervention: Be Well Plan program (5-week group-facilitated, internet-based intervention)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Be Well Plan program
Number of subjects: 215
Study: 35266409

Group type: EXPERIMENTAL
Intervention: Medication reduction (deprescribing antihypertensive medications)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (continuation of antihypertensive medications)
Number of subjects: 0
Study: 33256659

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with fluoxetine, 20 minutes of 2 mA stimulation, three times per week for 8 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoxetine only (sham control).
Number of subjects: 60
Study: 35468601

Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Brolucizumab 3 mg
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Brolucizumab
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Aflibercept 2 mg
Number of subjects: 1817
Study: 34477854

Group type: EXPERIMENTAL
Intervention: ON101 cream (n = 122)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Absorbent dressing (n = 114)
Number of subjects: 236
Study: 35783542

Group type: EXPERIMENTAL
Intervention: Persian herbal medicine formula + routine treatment
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 82
Study: 32096138

Group type: EXPERIMENTAL
Intervention: Superelastic Nickel‐titanium shape memory (SNT) rods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Titanium (Ti) rods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cobalt-chrome (Co‐Cr) rods
Number of subjects: 0
Study: 34253671

Group type: EXPERIMENTAL
Intervention: General practitioners examining patient records for harms, harm severity, and preventability.
Number of subjects: 9076
Study: 32643211

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of Care (SC)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Traditional Oral Health Education (TOHE)
Number of subjects: 180